Funding Journey
5 Funding Periods, 39 Investments, Clean SAFEs
$750K
Pre-Seed
2021
$4M-$5M Cap
$2.34M
Seed 1
2022-2023
$8M-$31M Cap
$540K
Seed 2
2024
$65M Cap
$5.93M
Seed 3
2025
$150M-$250M Cap
$5.47M
2026 SAFEs
2026
$250M Cap
39
Investments
Across 2021-2026
$5.47M
2026 SAFEs
7 investments at a $250M cap
3
Countries
Capital: US 88.7% | AU 10.3% | IN 1.0%
67.6%
Founders & Common
7.5M shares on a fully diluted basis
Figures reflect the September 2026 cap table. Investment totals include follow-on checks; ownership assumes SAFE conversion and the full 1.0M-share option pool.
Institutional Backers
Key Investors
CP Ventures
Venture Capital
First institutional backer of Skylark Labs
$700K combined across CapitalPitch and Denarii
Bommie Capital
Venture Capital — Lead Investor
$4.39M across 7 investment vehicles
Invested seven times — consistent follow-on conviction
Shock Ventures
Venture Capital
Early-stage defense and deep-tech focused fund
$100,952 SAFE at a $12.5M cap
CAVA
Cava Capital
Venture Capital — 2026 Investor
$2.10M via Cava Capital SPV XXI LLC
Largest new 2026 SAFE at a $250M cap
Family Office
Cushman & Family
Family Office
Strategic family office backing with deep real estate and infrastructure network
$200K SAFE investment
Strategic Investor
John Donovan
Former CEO, AT&T Communications
Board member at Lockheed Martin
$150K SAFE investment plus 15,000 advisor options
Valuation Evolution
Cap progression showing consistent upward trajectory
62.5x Valuation Growth
Group Entities
Skylark Labs India Pvt. Ltd. — Share Register
Registered Holder
Sukhbir Singh
Director, both entities
40,001 shares · 80.002%
Management advises these shares are held on behalf of Skylark Labs, Inc. The nominee declaration should be read alongside the Corporate Structure page.
Delaware Parent
Skylark Labs, Inc.
US parent corporation
9,999 shares · 19.998%
50,000 equity shares of ₹10 issued and fully paid, of an authorised 100,000. No shares were issued in FY2024-25, FY2025-26 or FY2026-27.
The capital structure above this section is Skylark Labs, Inc. (Delaware). The India entity has no option pool and no securities convertible into equity — both draft financial statements record that no shares are reserved under options or contracts for the sale of shares. All SAFEs and the option pool sit at the Delaware parent.